Raphanus sativus (Glucoraphasatin)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Raphanus sativus (Glucoraphasatin).

Glucoraphasatin serves as a thio-glycoside precursor to the isothiocyanate raphasatin, functioning as a potent inducer of Phase II detoxification enzymes and Nrf2-mediated antioxidant signaling to mitigate oxidative stress and hepatotoxicity.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

15559311

Molecular Weight

843.1 g/mol

XLogP3 (Lipophilicity)

2.1

IUPAC Name

2-[(4R,5S,6S,7R,9R,10S,11E,13E,16R)-6-[(2S,3R,4S,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Myrosinase for [Facilitating the enzymatic hydrolysis of glucoraphasatin into its bioactive isothiocyanate form]
Selenium for [Synergistic upregulation of thioredoxin reductase and glutathione peroxidase activity]

Biological Formulation Enhancers

Ascorbic Acid for [Acting as a cofactor for myrosinase to accelerate the conversion rate of glucosinolates]
Enteric Coating for [Protecting the myrosinase-glucosinolate complex from gastric acid degradation to ensure intestinal activation]

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Raphanus sativus (Glucoraphasatin) across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of concentrated Raphanus extracts necessitates the use of low-moisture HPMC capsules and desiccant packaging to maintain glucosinolate stability.

🍬 Gummy & Pectin Formats

The inherent sulfurous odor and pungent flavor profile of glucoraphasatin degradation products present significant organoleptic challenges requiring advanced flavor masking and low-heat processing.

🔬 Thin-Film Oral Strips

The high extract dosage required for therapeutic efficacy exceeds the typical 20-30mg payload capacity of thin-film polymer matrices, compromising strip flexibility and dissolution kinetics.

For Brand Founders

Formulate with Raphanus sativus (Glucoraphasatin)

Ready to launch a product featuring Raphanus sativus (Glucoraphasatin)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Raphanus sativus (Glucoraphasatin) Bioavailability

Need absolute proof that your Raphanus sativus (Glucoraphasatin) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Raphanus sativus (Glucoraphasatin) Degradation Testing

Is your Raphanus sativus (Glucoraphasatin) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation